SEC 13F Intelligence

Primecap Management Co/Ca/ / LLY

Primecap Management Co/Ca/’s Eli Lilly & Co Position

Does Primecap Management Co/Ca/ own Eli Lilly & Co (LLY)? Yes — 9.22M shares worth $8.5B (+6.68% of its 13F portfolio) as of Q1 2026, down from 9.27M shares the prior filed quarter.

Position Value
$8.5B
Q1 2026
Shares
9.22M
% of Portfolio
+6.68%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $5.9BQ4 ’18Q1 ’19: $5.6BQ2 ’19: $4.8BQ3 ’19: $4.8BQ4 ’19: $5.7BQ4 ’19Q1 ’20: $5.8BQ2 ’20: $6.5BQ3 ’20: $5.6BQ4 ’20: $6.2BQ4 ’20Q1 ’21: $6.6BQ2 ’21: $7.8BQ3 ’21: $7.6BQ4 ’21: $8.2BQ4 ’21Q1 ’22: $8.3BQ2 ’22: $9.2BQ3 ’22: $9.1BQ4 ’22: $9.5BQ4 ’22Q1 ’23: $8.7BQ2 ’23: $11.0BQ3 ’23: $12.4BQ4 ’23: $12.9BQ4 ’23Q1 ’24: $16.5BQ2 ’24: $17.8BQ3 ’24: $15.7BQ4 ’24: $12.9BQ4 ’24Q1 ’25: $12.2BQ2 ’25: $9.5BQ3 ’25: $8.2BQ4 ’25: $10.0BQ4 ’25Q1 ’26: $8.5Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.22M$8.5B+6.68%
Q4 20259.27M$10.0B+7.54%
Q3 202510.80M$8.2B+6.31%
Q2 202512.15M$9.5B+7.51%
Q1 202514.78M$12.2B+10.09%
Q4 202416.76M$12.9B+10.02%
Q3 202417.69M$15.7B+11.52%
Q2 202419.62M$17.8B+12.86%
Q1 202421.25M$16.5B+12.33%
Q4 202322.20M$12.9B+10.25%
Q3 202323.06M$12.4B+10.46%
Q2 202323.55M$11.0B+9.23%
Q1 202325.37M$8.7B+7.60%
Q4 202225.89M$9.5B+8.67%
Q3 202228.02M$9.1B+8.77%
Q2 202228.44M$9.2B+8.24%
Q1 202228.87M$8.3B+6.24%
Q4 202129.69M$8.2B+5.68%
Q3 202132.70M$7.6B+5.33%
Q2 202133.96M$7.8B+5.24%
Q1 202135.38M$6.6B+4.61%
Q4 202036.76M$6.2B+4.61%
Q3 202037.98M$5.6B+4.64%
Q2 202039.63M$6.5B+5.58%
Q1 202041.94M$5.8B+5.70%
Q4 201943.12M$5.7B+4.11%
Q3 201942.83M$4.8B+3.83%
Q2 201943.16M$4.8B+3.54%
Q1 201943.24M$5.6B+4.13%
Q4 201850.60M$5.9B+4.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Primecap Management Co/Ca/’s full portfolio or all institutional holders of LLY.